0001415889-23-011525.txt : 20230727
0001415889-23-011525.hdr.sgml : 20230727
20230727163043
ACCESSION NUMBER: 0001415889-23-011525
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230725
FILED AS OF DATE: 20230727
DATE AS OF CHANGE: 20230727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paolini John F.
CENTRAL INDEX KEY: 0001741533
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 231118937
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD.
STREET 2: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
FORMER NAME:
FORMER CONFORMED NAME: Paolini John
DATE OF NAME CHANGE: 20180522
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 7814399100
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
form4-07272023_080730.xml
X0508
4
2023-07-25
0001730430
Kiniksa Pharmaceuticals, Ltd.
KNSA
0001741533
Paolini John F.
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE 2 CHURCH STREET
HAMILTON
D0
HM 11
BERMUDA
false
true
false
false
CHIEF MEDICAL OFFICER
0
Class A Common Share
2023-07-25
4
M
0
29000
1.86
A
70910
D
Class A Common Share
2023-07-25
4
S
0
5200
18.01
D
65710
D
Class A Common Share
2023-07-25
4
S
0
16168
19.25
D
49542
D
Class A Common Share
2023-07-25
4
S
0
7632
19.69
D
41910
D
Share Option
1.86
2023-07-25
4
M
0
29000
0
D
2026-09-13
Class A Common Share
29000
140217
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on August 16, 2022.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.50 to $18.49. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $18.50 to $19.49. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $19.50 to $19.94. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
The option is fully vested and exercisable.
/s/ Madelyn Zeylikman, Attorney-in-Fact
2023-07-27